Stereo cell: A new approach to the next generation of clinical precision medicine

Abstract

Precision medicine has evolved through distinct phases, from the origins of the Human Genome Project to mutation-based targeted therapies. This editorial posits that “stereological cell biomedicine” could be a new approach promoting the development of the next generation of precision medicine. This emerging discipline transitions the focus from genomic data to the multi-dimensional and spatiotemporal complexity of single cells. Driven by advances in Stereo single-cell multi-omics (Stereo Cell-seq), spatial transcriptomics (Stereo-seq), and single-cell surfaceomics (sc-surfaceome), this approach aims to capture the stereologically dynamic interactions between organelles within a cell and between cells in the tissue. We argue that understanding the spatiotemporal location of molecules, particularly protein interactions at organelle interfaces and on the cell surface, is as critical as their abundance for defining cellular function in health and disease. Integrating these high-resolution measurements with artificial intelligence and computational modelling will bridge the gap between advanced omics and pathology. Initiatives such as the newly established European Stereo Cell Center (ESCC) signal a global shift towards this new paradigm, which promises to unlock novel diagnostic biomarkers and therapeutic targets for truly multi-factorial and dynamic precision medicine.

Keywords

precision medicine / sc-surfaceome / single-cell multi-omics / spatiotemporal / stereological cell biomedicine

References

[1] Haq MM. Medical genetics and the human genome project: a historical review. Tex Med. 1993; 89(3): 68-73.

[2] Wang T, Antonacci-Fulton L, Howe K, Lawson HA, Lucas JK, Phillippy AM, et al. The human pangenome project: a global resource to map genomic diversity. Nature. 2022; 604(7906): 437-446.

[3] National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press; 2011.

[4] Qian M, Li Q, Zhang M, Xu X, Shen Q, Chen H, et al. Multidisciplinary therapy strategy of precision medicine in clinical practice. Clin Transl Med. 2020; 10(1): 116-124.

[5] Wang DC, Wang W, Zhu B, Wang X. Lung cancer heterogeneity and new strategies for drug therapy. Annu Rev Pharmacol Toxicol. 2018; 58: 531-546.

[6] Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001; 344(14): 1031-1037.

[7] Gallagher CS, Ginsburg GS, Musick A. Biobanking with genetics shapes precision medicine and global health. Nat Rev Genet. 2025; 26(3): 191-202.

[8] Juweid ME, Al-Qasem SF, Khuri FR, et al. Beyond fluorodeoxyglucose: molecular imaging of cancer in precision medicine. CA Cancer J Clin. 2025; 75(3): 226-242.

[9] Song F, Hu B, Liang XL, Cheng JW, Wang CG, Wang PX, et al. Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8+ T-cell infiltration in hepatocellular carcinoma. Clin Transl Med. 2024; 14(8):e1738.

[10] Wang X, Powell CA, Ma Q, Fan J. Clinical and translational mode of single-cell measurements: an artificial intelligent single-cell. Clin Transl Med. 2024; 14(9):e1818.

[11] Liu X, Powell CA, Wang X. Forward single-cell sequencing into clinical application: understanding of cancer microenvironment at single-cell solution. Clin Transl Med. 2022; 12(4):e782.

[12] Liu F, Liu X, Powell CA, et al. Initiative of clinical single-cell biomedicine in clinical and translational medicine. Clin Transl Med. 2023; 13(1):e1173.

[13] Yan F, Li Z, Powell CA, Wang X. Forward single-cell sequencing into clinical application: understanding of ageing and rejuvenation from clinical observation to single-cell solution. Clin Transl Med. 2022; 12(5):e827.

[14] Wang W, Liu X, Wang DC. Single-cell and spatial alterations of neural cells and circuits in clinical and translational medicine. Clin Transl Med. 2024; 14(6):e1696.

[15] Sheridan C. Can single-cell biology realize the promise of precision medicine?. Nat Biotechnol. 2024; 42(2): 159-162.

[16] Jonghe JD, Opzoomer JW, Vilas-Zornoza A, Crane P, Nilges BS, Vicari M, et al. A community effort to track commercial single-cell and spatial 'omic technologies and business trends. Nat Biotechnol. 2024; 42(7): 1017-1023.

[17] Liu X, Wang DC, Powell CA, Wang X. Challenges of clinical translation from single-cell sequencing to measures in clinical biochemistry of haematology: definition of immune cell identities. Clin Transl Med. 2023; 13(9):e1401.

[18] Liu X, Xu G, Chen C, Song Y, Wang W, Wang X. Evaluation of pulmonary single-cell identity specificity in scRNA-seq analysis. Clin Transl Med. 2022; 12(12):e1132.

[19] Liao S, Zhou X, Liu C, Liu C, Hao S, Luo H, et al. Stereo-cell: spatial enhanced resolution single-cell sequencing with high-density DNA nanoball-patterned arrays. Science. 2025; 389(6762):eadr0475.

[20] Liu X, Duan W, Qiu Y, Li R, Song Y, Wang X. Significance of stereologically spatiotemporal cells in molecular medicine. Clin Transl Med. 2025; 15(9):e70470.

[21] Guigas G, Weiss M. Effects of protein crowding on membrane systems. Biochim Biophys Acta. 2016; 1858(10): 2441-2450.

[22] Leung KK, Schaefer K, Lin Z, Yao Z, Wells JA. Engineered proteins and chemical tools to probe the cell surface proteome. Chem Rev. 2025; 125(8): 4069-4110.

[23] Hein MY, Peng D, Todorova V, McCarthy F, Kim K, Liu C, et al. Global organelle profiling reveals subcellular localization and remodeling at proteome scale. Cell. 2025; 188(4): 1137-1155. e20.

[24] Baumgartner C. Stereo-cell: advancing spatial single-cell biology towards clinical translation. Clin Transl Med. 2025; 15(9):e70480.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.